SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 426.61 |
| Enterprise Value ($M) | 292.76 |
| Book Value ($M) | 179.00 |
| Book Value / Share | 5.52 |
| Price / Book | 2.38 |
| NCAV ($M) | 149.62 |
| NCAV / Share | 4.62 |
| Price / NCAV | 2.85 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.40 |
| Return on Assets (ROA) | -0.40 |
| Return on Equity (ROE) | -0.49 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 15.78 |
| Current Ratio | 15.78 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 177.62 |
| Assets | 207.00 |
| Liabilities | 28.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -84.77 |
| Net Income | -78.63 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -69.00 |
| Cash from Investing | -32.00 |
| Cash from Financing | -0.19 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Oxford Science Enterprises plc | 14.70 | ||
| 13D/A | Ra Capital Management, L.p. | 33.10 | 0.00 | |
| 13G/A | Viking Global Investors Lp | 6.20 | -4.03 | |
| 13G/A | Fmr Llc | 3.10 | -71.38 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K/A Amendment No. 1 | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 5,149 | 50,884 | 10.12 | |
| 3,347 | 19,932 | 16.79 | |
| 4,023 | 9,489 | 42.40 | |
| 5,849 | 39,991 | 14.63 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PBYI – Puma Biotechnology, Inc. | PCRX – Pacira BioSciences, Inc. |
| PCVX – Vaxcyte, Inc. | PGEN – Precigen, Inc. |
| PHAT – Phathom Pharmaceuticals, Inc. |
Financial data and stock pages provided by
Fintel.io